Cognos Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Cognos Therapeutics's estimated annual revenue is currently $1.9M per year.
- Cognos Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Cognos Therapeutics has 12 Employees.
- Cognos Therapeutics grew their employee count by 0% last year.
Cognos Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP R&D | Reveal Email/Phone |
3 | Senior Consultant Artificial Intelligence & Automation | Reveal Email/Phone |
Cognos Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Cognos Therapeutics?
Cognos Therapeutics Inc. (Cognos) is an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases including tumor-based brain and spinal cancers, degenerative cognition disorders (such as Alzheimer’s and Parkinson’s disease), cerebral trauma occurrences (such as epilepsy and stroke) as well as other Central Nervous System afflictions.
keywords:N/A
N/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Inglewood
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.8M | 13 | -61% | N/A |
#2 | N/A | 13 | -79% | N/A |
#3 | $0.9M | 15 | 0% | N/A |
#4 | $2.1M | 17 | N/A | N/A |
#5 | $3M | 17 | -39% | N/A |